SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 90.7 TWD -1.41% Market Closed
Market Cap: 6.4B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

Operating Margin
SciVision Biotech Inc

30%
Current
26%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
30%
=
Operating Profit
249.1m
/
Revenue
831.4m

Operating Margin Across Competitors

Country TW
Market Cap 6.4B TWD
Operating Margin
30%
Country JP
Market Cap 6.8T JPY
Operating Margin
28%
Country CH
Market Cap 38.7B CHF
Operating Margin
13%
Country DK
Market Cap 204B DKK
Operating Margin
27%
Country US
Market Cap 17.2B USD
Operating Margin
17%
Country KR
Market Cap 9.8T KRW
Operating Margin
-245%
Country CN
Market Cap 51B CNY
Operating Margin
45%
Country CA
Market Cap 7B USD
Operating Margin
4%
Country US
Market Cap 6.3B USD
Operating Margin
32%
Country UK
Market Cap 4.9B GBP
Operating Margin
13%
Country US
Market Cap 6B USD
Operating Margin
12%
No Stocks Found

SciVision Biotech Inc
Glance View

Market Cap
6.4B TWD
Industry
Health Care

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

Intrinsic Value
178.54 TWD
Undervaluation 49%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
30%
=
Operating Profit
249.1m
/
Revenue
831.4m
What is the Operating Margin of SciVision Biotech Inc?

Based on SciVision Biotech Inc's most recent financial statements, the company has Operating Margin of 30%.